Aurinia Pharmaceuticals, Inc. holding history
As of Nov. 6, 2026 (UTC)
| March 31, 2025 | 70,099 | $563,596 | 0.00% | Withheld — Comparison unavailable: Comparable change withheld pending corporate-action review | May 6, 2025 |
| June 30, 2025 | 116,203 | $984,239 | 0.00% | Withheld — Comparison unavailable: Comparable change withheld pending corporate-action review | Aug. 12, 2025 |
| Sept. 30, 2025 | 116,203 | $1,284,043 | 0.01% | Withheld — Comparison unavailable: Comparable change withheld pending corporate-action review | Nov. 5, 2025 |
| Dec. 31, 2025 | 92,212 | $1,470,781 | 0.01% | Withheld — Comparison unavailable: Comparable change withheld pending corporate-action review | Feb. 6, 2026 |
| March 31, 2026 | 92,212 | $1,366,582 | 0.01% | Withheld — Comparison unavailable: Comparable change withheld pending corporate-action review | May 7, 2026 |
| June 30, 2026 | 92,212 | $1,564,838 | 0.01% | Withheld — Comparison unavailable: Comparable change withheld pending corporate-action review | Aug. 6, 2026 |
6 rows · Sort by column; scroll horizontally for more.
No rows match these filters.
Schedule 13G disclosures
No verified related disclosures are included in this freeze.
About reported holdings
13F reports quarter-end securities, excluding cash and shorts. Position changes do not establish trades, motives or returns; portfolio weights use disclosed 13F value.